EUVIMEDEUVIMED entdecken
Crossref

Targeted RNA Degradation via LipoSM-RiboTAC Nanoparticles: A Versatile Platform for Cancer Therapy

Zijun Jiao iD, Chunli Song iD, Xinrui Sha iD, Ying Chen, Yun Xing, Fuqing Yang, Rui Wang iD, Yuxin Ye iD, Zhihong Liu, Zi-You Tian, Zigang Li iD, Feng Yin iD

Journal of the American Chemical Society · 2025

DOI: 10.1021/jacs.5c04884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Zijun Jiao und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen 518…. Hauptthemen laut MEDLINE: Nanoparticles, RNA Stability, Liposomes, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fun-damental Research Institutions, Shenzhen Medical Research Fund, CCF-Tencent Rhino-Bird Open Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesRNA StabilityLiposomesNeoplasmsRNAAntineoplastic AgentsEndoribonucleasesHumansRibonucleasesCell Line, Tumor

Substanzen

LiposomesRNAAntineoplastic AgentsRibonucleasesEndoribonucleases

Autor:innen und Institutionen

  • State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen 518055, China.
  • Pingshan Translational Medicine Center, Shenzhen Bay Laboratory, Shenzhen 518118, China.

ORCID-Profile: Zijun Jiao, Chunli Song, Xinrui Sha, Rui Wang, Yuxin Ye, Zigang Li, Feng Yin

Förderung

  • Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fun-damental Research Institutions
  • Shenzhen Medical Research Fund
  • CCF-Tencent Rhino-Bird Open Research Fund
  • Shenzhen Sustainable Supporting Funds for Colleges and Universities
  • Frontiers Medical Center, Tianfu Jincheng Laboratory Foun-dation
  • National Center for Biological Medicine Technology Innovation
  • High-tech Zone Development Special Project of Shenzhen
  • Shenzhen Science and Technology Program

Zitieren

APA

Jiao, Z., Song, C., Sha, X., Chen, Y., Xing, Y., Yang, F., Wang, R., Ye, Y., Liu, Z., Tian, Z. Y., Li, Z., & Yin, F. (2025). Targeted RNA Degradation via LipoSM-RiboTAC Nanoparticles: A Versatile Platform for Cancer Therapy. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c04884

Vancouver

Jiao Z, Song C, Sha X, Chen Y, Xing Y, Yang F, et al. Targeted RNA Degradation via LipoSM-RiboTAC Nanoparticles: A Versatile Platform for Cancer Therapy. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.5c04884

BibTeX
@article{Jiao2025,
  author = {Jiao, Zijun and Song, Chunli and Sha, Xinrui and Chen, Ying and Xing, Yun and Yang, Fuqing and Wang, Rui and Ye, Yuxin and Liu, Zhihong and Tian, Zi-You and Li, Zigang and Yin, Feng},
  title = {Targeted RNA Degradation via LipoSM-RiboTAC Nanoparticles: A Versatile Platform for Cancer Therapy},
  journal = {Journal of the American Chemical Society},
  year = {2025},
  doi = {10.1021/jacs.5c04884}
}
Kostenlos starten →